- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
January 23, 2013, Copenhagen, Denmark, and Shenzhen, China – Accompanied by Mr. Morten Mølgaard Jensen, the CEO of Copenhagen Bio Science Park (COBIS), Ms. Ayfer Baykal, the Lord Mayor of Copenhagen visited BGI’s European Genome Research Center. A warm welcome was given by Ms. Ruiqi Xu, Regional Director of Denmark of BGI Europe, and Ms. Catherine Gao, Marketing Communication Manager of BGI Europe.
Ms. Ruiqi Xu delivered a brief introduction about the history and development of BGI Europe and its European Genome Research Center. She said, “The goal of establishing a genome center in Copenhagen is to better and conveniently provide BGI´s world-class expertise and infrastructure for European researchers and scientists. We believe the center will help to add immense value on science advancement and application for both BGI Europe and Danish life science research communities in the near future.”
Ms. Ayfer Baykal expressed her appreciation to BGI’s leaders that they could choose Copenhagen as their European headquarter. During this visit, the Mayor’s delegation also showed their pleasure to visit BGI Europe and its genome research center. All of them were impressed by BGI’s robust sequencing capacity and the abundance of projects and experiences in Omics research. Meanwhile, they expressed their great confidence in the glorious future of BGI’s genome research center in Europe.
BGI’s first European Genome Research Center, located in Copenhagen Bio Science Park (COBIS), is about 1,200 square meters and equipped with 10 Illumina HiSeq 2000 sequencers. The center was launched in February, 2012, and its aim is to establish collaborations to better accelerate the innovation and development of genomics research and applications in health care, agriculture, bioenergy and other related areas in Europe.